ASTH: the cashflow

MyFinsight

For the quarter ending 2025-09-30, ASTH had $123,976K increase in cash & cash equivalents over the period. $7,404K in free cash flow.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net income	1,077	16,437
Depreciation and amortization	15,596	13,752
Amortization of debt issuance cost	1,152	1,740
Share-based compensation	7,700	19,519
Non-cash lease expense	1,789	2,559
Deferred tax	-2,963	-1,961
Other	1,051	3,910
Changes in operating assets and liabilities, net of business combinations	-15,446	51,571
Net cash provided by operating activities	9,956	107,527
Payments for business acquisitions, net of cash acquired	548,553	0
Proceeds from sale of equity method investment	15,100	-
Purchases of investments equity method	0	0
Purchase of call option issued in conjunction with equity method investment	0	0
Issuance of loan receivable	658	1,050
Purchases of property and equipment	2,552	4,490
Other	-2,192	-2,069
Net cash used in investing activities	-534,471	-3,471
Dividends paid	96	6,233
Borrowings on long-term debt	707,300	412,000
Repayment of long-term debt	51,966	431,357
Deferred financing cost	1,964	17,241
Payment of contingent liabilities	8,284	-
Taxes paid from net share settlement of restricted stock	509	5,053
Other	4,010	-4,924
Net cash provided by financing activities	648,491	-52,808
Net increase in cash, cash equivalents, and restricted cash	123,976	51,248
Cash and cash equivalents at beginning of period	289,102	-
Cash and cash equivalents at end of period	464,326	-

Unit: Thousand (K) dollars